The market is expected to reach USD 1.1 Billion by 2020 at CAGR of 7.2% from 2015 to 2020
Seattle, WA -- (SBWIRE) -- 06/26/2017 -- The report "Continuous Renal Replacement Therapy (CRRT) Market by Products (System, Disposables (Hemofilters & Bloodlines), & Dialysate/Replacement Fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF) and Geography - Regional Adoption and Global Forecasts to 2020", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and Rest of the World (RoW). The market is expected to reach USD 1.1 Billion by 2020 at CAGR of 7.2% from 2015 to 2020.
Browse 76 market data Tables and 66 Figures spread through 174 Pages and in-depth TOC on "Continuous Renal Replacement Therapy (CRRT) Market"
Early buyers will receive 10% customization on reports.
On the basis of product, the CRRT market is classified into CRRT systems, CRRT disposables, and dialysate & replacement fluids. The diagnostic CRRT disposables segment is further divided into hemofilters, bloodlines, and other disposables. On the basis of modality, the CRRT market is categorized into slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF).
Get The PDF Brochure For This Report@
Factors such as growing aging population, increasing number of AKI patients, technological advancements & new product launches, rising adoption of CRRT for the treatment of renal disorders, and clinical advantages of CRRT over intermittent blood purification techniques are driving the growth of the global CRRT market. However, factors such as the high complexity & procedural costs of CRRT therapy and a dearth of trained ICU nurses across the globe have been hampering the growth of this market.
Ask for Discount on this Report@
Europe is estimated to account for the largest share of the market in 2015, followed by North America. However, the Asia-Pacific market is expected to grow at the highest CAGR of ~8.7% from 2015 to 2020. This high growth can be attributed to the rapidly increasing aging population, rising sepsis incidence, growing focus of multinational companies on emerging markets, and improving and modernizing healthcare infrastructure in this region.
Some major players in the global CRRT market are Asahi Kasei Medical Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (U.S.), Bellco S.r.l. (Italy), Fresenius Medical Care AG & Co. KGaA (Germany), Infomed SA (Switzerland), Medica S.p.A (Italy), Medical Components, Inc. (U.S.), Nikkiso Co., Ltd (Japan), NxStage Medical, Inc. (U.S.), and Toray Medical Company Limited (Japan).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States